Clinical efficacy of anticoagulant therapy combined with apatinib mesylate in the treatment of venous thrombosis in patients with malignant solid tumors and data analysis of related risk factors
第一作者机构：[1]Hebei Med Univ, Dept Med Oncol, Hosp 4, Shijiazhuang, Hebei, Peoples R China
推荐引用方式(GB/T 7714)：
Li Ying,Cui Yanzhi,Zhang Hui,et al.Clinical efficacy of anticoagulant therapy combined with apatinib mesylate in the treatment of venous thrombosis in patients with malignant solid tumors and data analysis of related risk factors[J].ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY.2022,18:21-21.
APA：
Li, Ying,Cui, Yanzhi,Zhang, Hui,Huang, Fang&Zhang, Xue.(2022).Clinical efficacy of anticoagulant therapy combined with apatinib mesylate in the treatment of venous thrombosis in patients with malignant solid tumors and data analysis of related risk factors.ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY,18,
MLA：
Li, Ying,et al."Clinical efficacy of anticoagulant therapy combined with apatinib mesylate in the treatment of venous thrombosis in patients with malignant solid tumors and data analysis of related risk factors".ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 18.(2022):21-21
